MIA continues to be a world-leader in developing, leading and running clinical trials that provide breakthrough treatments for melanoma. Clinical trials are a crucial part of the research undertaken at MIA.

All our patients have the opportunity to participate in clinical trials, and by doing so, become part of the concerted research effort to develop treatments which will ultimately save all lives from the disease.

Clinical trials are coordinated from The Poche Centre in Wollstonecraft and conducted at locations throughout our network.

View our Clinical Trials brochure by clicking on the cover image below to find out more about clinical trials. The brochure is available in English and Simplified Chinese.

Clinical Trials – English

Clinical Trials – Simplified Chinese

Current Clinical Trials

MIA offers many clinical trials for patients with melanoma and non-melanoma skin cancers.
For up-to-date information on currently recruiting and upcoming clinical trials, visit the clinical trials page.

Spotlight on specific Clinical Trials

ABC-X Clinical Trial

The ABC-X clinical trial is seeking to determine if adding stereotactic radiotherapy (SRS) to treatment with combination immunotherapy will result in improved long-term intracranial control in patients with asymptomatic melanoma brain metastases.